Profile data is unavailable for this security.
About the company
Pharvaris BV is a Switzerland-based clinical-stage company. The activity of the Company focuses on producing oral bradykinin B2-receptor antagonists and is advancing new alternatives to injected therapies for all sub-types of hereditary angioedema (HAE).
- Revenue in USD (TTM)0.00
- Net income in USD-115.70m
- Incorporated2015
- Employees82.00
- LocationPharvaris NVJ.H. Oortweg 21LEIDEN 2333 CHNetherlandsNLD
- Websitehttps://pharvaris.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ProKidney Corp | 0.00 | -35.30m | 834.11m | 163.00 | -- | -- | -- | -- | -0.567 | -0.567 | 0.00 | -17.79 | 0.00 | -- | -- | 0.00 | -30.32 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0004 | -- | -- | -- | 67.17 | -- | -- | -- |
ARS Pharmaceuticals Inc | 10.00k | -49.70m | 854.62m | 24.00 | -- | 3.80 | -- | 85,461.62 | -0.5198 | -0.5198 | 0.0001 | 2.32 | 0.00004 | -- | -- | 416.67 | -19.93 | -20.37 | -20.48 | -21.32 | -- | -- | -496,960.00 | -17,491.75 | -- | -- | 0.00 | -- | -97.72 | -- | -56.75 | -- | -17.18 | -- |
Humacyte Inc | 0.00 | -105.70m | 871.70m | 183.00 | -- | 33.33 | -- | -- | -1.01 | -1.01 | 0.00 | 0.2196 | 0.00 | -- | -- | 0.00 | -61.38 | -- | -68.92 | -- | -- | -- | -- | -- | -- | -61.50 | 0.4145 | -- | -100.00 | -- | -825.83 | -- | -- | -- |
Arcutis Biotherapeutics Inc | 106.39m | -217.42m | 879.81m | 296.00 | -- | 3.90 | -- | 8.27 | -2.91 | -2.91 | 1.30 | 1.95 | 0.248 | 0.6845 | 4.26 | 359,439.20 | -50.68 | -65.64 | -56.21 | -71.72 | 92.99 | -- | -204.36 | -1,513.03 | 9.61 | -6.52 | 0.4741 | -- | 1,517.09 | -- | 15.83 | -- | -- | -- |
Disc Medicine Inc | 0.00 | -80.60m | 901.34m | 74.00 | -- | 2.66 | -- | -- | -3.37 | -3.37 | 0.00 | 13.69 | 0.00 | -- | -- | 0.00 | -26.96 | -- | -28.13 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -63.22 | -- | -- | -- |
Pharvaris NV | 0.00 | -115.70m | 904.66m | 82.00 | -- | 2.31 | -- | -- | -2.59 | -2.59 | 0.00 | 7.27 | 0.00 | -- | -- | 0.00 | -40.45 | -36.09 | -43.50 | -38.27 | -- | -- | -- | -- | -- | -127.47 | 0.0005 | -- | -- | -- | -32.15 | -- | -- | -- |
Immunome Inc | 12.68m | -232.03m | 908.53m | 55.00 | -- | 3.17 | -- | 71.63 | -5.49 | -5.49 | 0.4273 | 4.78 | 0.069 | -- | -- | 230,600.00 | -126.15 | -94.54 | -148.61 | -112.66 | -- | -- | -1,829.44 | -1,403.15 | -- | -- | 0.00 | -- | -- | -- | -184.68 | -- | 29.52 | -- |
Gyre Therapeutics Inc | 140.62m | -85.66m | 920.09m | 593.00 | -- | 16.23 | -- | 6.54 | -1.88 | -1.88 | 1.55 | 0.663 | 2.00 | -- | 13.75 | 237,136.60 | -107.71 | -73.59 | -184.22 | -99.94 | 96.01 | -- | -53.91 | -205.62 | 2.97 | -- | 0.00 | -- | 14,188.41 | 616.69 | -1,027.55 | -- | 86.95 | -- |
USANA Health Sciences, Inc. | 900.45m | 61.94m | 931.19m | 1.80k | 15.26 | 1.86 | 12.49 | 1.03 | 3.20 | 3.20 | 46.56 | 26.25 | 1.46 | 2.73 | -- | 500,250.00 | 10.03 | 16.23 | 12.49 | 21.75 | 80.98 | 81.42 | 6.88 | 8.96 | 3.20 | -- | 0.0026 | 0.00 | -7.77 | -4.98 | -8.02 | -12.76 | 4.86 | -- |
OPKO Health Inc | 799.60m | -252.43m | 933.97m | 3.93k | -- | 0.7455 | -- | 1.17 | -0.3427 | -0.3427 | 1.08 | 1.80 | 0.3859 | 7.53 | 6.87 | 203,461.30 | -12.18 | -7.14 | -13.58 | -8.14 | 32.63 | 34.42 | -31.56 | -13.83 | 1.58 | -4.96 | 0.2217 | -- | -14.01 | -2.70 | 42.49 | -- | -10.19 | -- |
Silence Therapeutics plc | 33.77m | -44.68m | 947.20m | 115.00 | -- | 6.69 | -- | 28.05 | -0.3926 | -0.3926 | 0.2867 | 1.14 | 0.1829 | -- | 5.37 | 293,647.00 | -24.20 | -43.60 | -27.21 | -54.91 | 69.72 | -- | -132.31 | -287.30 | -- | -- | 0.0022 | -- | 44.99 | -- | -6.86 | -- | 156.10 | -- |
Enliven Therapeutics Inc | 0.00 | -79.60m | 950.14m | 46.00 | -- | 2.97 | -- | -- | -1.93 | -1.93 | 0.00 | 6.79 | 0.00 | -- | -- | 0.00 | -24.66 | -42.26 | -26.11 | -46.62 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -4,910.75 | -- | -- | -- |
Cassava Sciences Inc | 0.00 | -47.90m | 956.64m | 29.00 | -- | 10.97 | -- | -- | -1.17 | -1.17 | 0.00 | 1.82 | 0.00 | -- | -- | 0.00 | -25.63 | -30.74 | -33.88 | -32.12 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -27.50 | -- | -- | -- |
Relay Therapeutics Inc | 35.33m | -329.12m | 965.03m | 309.00 | -- | 1.29 | -- | 27.32 | -2.64 | -2.64 | 0.2841 | 5.64 | 0.0376 | -- | -- | 109,371.50 | -35.03 | -28.55 | -37.16 | -29.54 | -- | -- | -931.64 | -998.20 | -- | -- | 0.00 | -- | 1,749.82 | -- | -17.72 | -- | 19.59 | -- |
Nurix Therapeutics Inc | 80.89m | -144.73m | 968.43m | 284.00 | -- | 4.76 | -- | 11.97 | -2.65 | -2.65 | 1.48 | 3.43 | 0.2369 | -- | -- | 284,813.40 | -42.39 | -33.01 | -54.58 | -39.66 | -- | -- | -178.93 | -260.65 | -- | -- | 0.00 | -- | 99.31 | 15.50 | 20.19 | -- | 39.42 | -- |
Data as of Jun 10 2024. Currency figures normalised to Pharvaris NV's reporting currency: US Dollar USD
Holder | Shares | % Held |
---|---|---|
Fidelity Management & Research Co. LLCas of 31 Mar 2024 | 5.19m | 9.65% |
Viking Global Investors LPas of 31 Mar 2024 | 3.65m | 6.79% |
Commodore Capital LPas of 31 Mar 2024 | 1.73m | 3.21% |
Cormorant Asset Management LPas of 31 Mar 2024 | 1.71m | 3.18% |
EcoR1 Capital, LLCas of 31 Mar 2024 | 900.00k | 1.67% |
T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 2024 | 757.92k | 1.41% |
Rock Springs Capital Management LPas of 31 Mar 2024 | 752.92k | 1.40% |
Soleus Capital Management LP (Investment Management)as of 31 Mar 2024 | 401.90k | 0.75% |
Sphera Funds Management Ltd.as of 31 Mar 2024 | 392.88k | 0.73% |
LSP Advisory BVas of 31 Dec 2023 | 211.20k | 0.39% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.